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SITE-DIRECTED MUTAGENESIS APPLICATIONS ON TARGET SITES 
OF cmFDH TO IMPROVE THERMOSTABILITY 
SUMMARY 
NAD
+
-dependent formate dehydrogenases catalyse the oxidation of formate anion 
into carbon dioxide, coupled with the reduction of NAD
+
 to NADH. Dehydrogenases 
can be used in the synthesis of optically active compounds that are used in industrial 
applications since different optical isomers of the same compound may cause 
diseases due to the opposite physiological effects. Among dehydrogenases, formate 
dehydrogenases have high benefits in the application of NAD(P)
+
 reduction such as 
using a cheap substrate, easily product removal, wide catalytic range of optimum pH, 
high efficiency etc. However, it has disadvantages on industrial applications since it 
can be easily inactivated above 55°C. Therefore, a thermostable enzyme is desired to 
facilitate its usage in large scale applications.  In order to overcome this 
thermostability problem, many attemps either by rational design or directed evolution 
have been applied with resulting in significant outcomes.  
In this project, the thermostability of FDH from Candida methylica (cm) was aimed 
to be improved by changing some defined amino acid residues by site-directed 
mutagenesis which is a rational design strategy. The design was performed by the 
combination of two structural features that are protein cavity and flexibility. 
According to the results of homology modeling studies of cmFDH based on Candida 
boidinii (cb) FDH and Pseudomonas sp. (pse) FDH crystal structure, the cavities and 
the target sites in cavity-lining residues were identified as critical points for the 
flexibility of enzyme. Cavities with the potential of taking part in catalytic activity 
were excluded. Then, computational method was applied to the remaining 
appropriate residues and feasible mutations on these residues were suggested. 
M131A, K301R, V133I, V139W mutant cmFDHs were aimed to be produced and 
purified from BL21 cells and thermal denaturation profiles were developed following 
kinetic activity studies. The study resulted with improved thermostability on two of 
the four mutants, which are K301R and V133I. Additionally; after manipulation on 
defined residues, catalytic efficiency of the enzyme was seen as increased in the 
V139W mutant, while other three mutants resulted with reduced catalytic efficiency. 
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cmFDH ENZİMİNİN TERMOSTABİLİTESİNİN GELİŞTİRİLMESİNE 
YÖNELİK HEDEF BÖLGELER ÜZERİNDE BÖLGEYE ÖZEL MUTASYON 
UYGULAMALARI 
ÖZET 
 
NAD
+
-bağımlı format dehidrogenaz enzimleri format molekülünün karbondioksite 
oksidasyonunu katalizler. Bu reaksiyona, NAD
+ molekülünün NADH molekülüne 
indirgenmesi eşlik eder. Aynı bileşiğin farklı optik izomerlerinin organizmada yol 
açabileceği zararlı etkilerinden korunmak amacıyla endüstriyel uygulamalarda 
sıklıkla optikçe aktif saf bileşikler tercih edilmektedir. 
Optikçe aktif bileşiklerin sentezinde dehidrogenaz enzimleri kullanılır ve bunların 
arasından format dehidrogenazların NAD(P)+ rejenerasyonu açısından büyük bir 
önemi bulunmaktadır. Substratının ucuz ve kolay temin edilebilir bir bileşik olması, 
reaksiyon ürünü olarak karbon dioksidin ortamdan kolayca uzaklaştırılabilmesi, 
enzimin geniş bir pH aralığında çalışabiliyor olması, yüksek verimli reaksiyon 
vermesi gibi bir çok avantajlarının yanında format dehidrogenaz enziminin 
endüstriyel uygulamalarda kullanımı, sıcaklığın 55°C’nin üstüne çıkması durumunda 
enzimin inaktive olması sebebiyle kısıtlıdır. Bu sebeple, geniş ölçekli çalışmalarda 
kullanımı kolaylaştırmak amacıyla yüksek ısıya dayanıklı enzimler istenmektedir. 
Böyle bir dayanıksızlığın üstesinden gelebilmek için günümüze kadar hem rasyonel 
dizayn hem yönlendirilmiş evrim çalışmalarıyla çeşitli girişimlerde bulunulmuş ve 
önemli sonuçlar elde edilmiştir. 
Bu projede, Candida methylica mikroorganizmasından elde edilen format 
dehidrogenaz (FDH) enziminin termostabilitesi artırılmaya çalışılmıştır. Çalışmada, 
bir rasyonel dizayn stratejisi olarak bölgeye özel mutasyon yöntemi tercih edilmiştir. 
Bu sayede belirli birkaç amino asit üzerinde önerilen diğer bir amino asitle değişiklik 
amaçlanmıştır. Candida boidinii FDH ve Pseudomonas sp. FDH enzimlerinin kristal 
yapısı esas alınarak gerçekleştirilen homoloji modelleme çalışmalarının sonuçlarına 
göre, enzim üzerinde oyuk oluşturan amino asitler önceki çalışmalarda belirlenmiş 
olup, bunların enzimin esnekliği üzerinde kritik bir öneme sahip oldukları ortaya 
konulmuş ve hedef bölgeler tayin edilmiştir. 
Homoloji çalışmalarında, yüksek sıcaklıklara karşı enzimin stabil kalmasını 
etkilediği düşünülen iki önemli özellik, protein oyukları ve enzimin esnekliği esas 
alınmıştır. Homoloji modelleme çalışmalarının sonuçlarına göre; daha önceden 
hesaplamalı yöntemlerle belirlenmiş cmFDH enzimi üzerindeki on dört oyuktan altı 
tanesinin termostabilite üzerinde, enzimin aktivitesini ve kofaktör molekülünün 
bağlanmasını etkilemeyecek derecede kritik bir öneme sahip oldukları ortaya 
konmuştur. İlk olarak; 1. oyuk, 3. oyuk, 4. oyuk, 5. oyuk, 6. oyuk, 7. oyuk ve 14. 
oyuk olmak üzere toplam yedi adet oyuğun termostabiliteyle ilişkilendirilebilecek 
derecede esnek bölgelere sahip olduğu belirlenmiştir. Ancak, NAD+ bağlayıcı 
bölgede yer alması ve herhangi bir olası mutasyona karşı hassasiyet gösterebilecek 
olması sebebiyle 7 numaralı oyuk seçenekler arasından çıkartılmış ve enzim üzerinde 
kalan altı oyuk mutasyon çalışmaları için seçilmiştir. Bu çalışmada ise, belirlenen 
hedef bölgelerden katalitik aktivitede rolü olanlar elenmiş ve üzerlerinde yapılan 
sayısal hesaplamalarla önerilen mutantlar esas alınarak Candida methylica FDH 
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(cmFDH) üzerinde dört farklı bölgede tekli mutasyonların oluşturulması 
amaçlanmıştır. 131. bölgede metiyonin amino asidinin alanin amino asidiyle 
değiştirilmesiyle oluşturulan M131A mutantı; 301. bölgede lizin amino asidinin 
arjinin amino asidiyle değiştirilmesiyle oluşturulan K301R mutantı; 133. bölgede 
valin amino asidinin izolösin amino asidiyle değiştirilmesiyle oluşturulan V133I 
mutantı ve 139. bölgede valin amino asidinin triptofan amino asidiyle 
değiştirilmesiyle oluşturulan V139W mutantının üretimi için ilk adım olarak, belirli 
bölgede ilgili mutasyonu içeren spesifik primerlerle polimeraz zincir reaksiyonları 
kurularak genin amplifikasyonu sağlanmıştır. M131A mutant dizisinin oluşturulması 
için kullanılan primer, içerisinde orijinal dizide metiyonin amino asidini kodlayan 
ATG kodonu yerine alanin amino asidini kodlayan GCC kodonu bulunacak şekilde 
dizayn edilmiştir. K301R mutant dizisinin oluşturulması için kullanılan primer, 
içerisinde orijinal dizide lizin amino asidini kodlayan AAA kodonu yerine arjinin 
amino asidini kodlayan CGT kodonu bulunacak şekilde dizayn edilmiştir. V133I 
mutant dizisinin oluşturulması için kullanılan primer, içerisinde orijinal dizide valin 
amino asidini kodlayan GTC kodonu yerine izolösin amino asidini kodlayan ATT 
kodonu bulunacak şekilde dizayn edilmiştir. V139W mutant dizisinin oluşturulması 
için kullanılan primer ise, içerisinde orijinal dizide valin amino asidini kodlayan 
GTT kodonu yerine triptofan amino asidini kodlayan TGG kodonu bulunacak şekilde 
dizayn edilmiştir. İlgili mutasyonları içeren dizilerin amplifikasyonu için 
denatürasyon, bağlanma ve uzama aşamalarının otuz döngü sayısı ile yürütüldüğü 
mutagenez polimeraz zincir reaksiyonu (PZR) gerçekleştirilmiştir.   
Mutagenez PZR sonucunda reaksiyon ürünlerinin eldesi agaroz jel elektroforezi ile 
kontrol edilmiştir. Jel üzerindeki örneklerin UV ışığı altında görüntülemelerinin 
yapılmasıyla vektör ve cmFDH dizisini içeren yaklaşık 6000 baz çifti uzunluğundaki 
plazmidin doğrulaması yapılmıştır. 
Reaksiyon ürünlerinden mutasyon içermeyen DNA’ları elemek amacıyla DpnI 
enzimiyle kesim işlemi yapılmış ve ürünler saflaştırılmıştır. Reaksiyon ürünlerinin 
elektrokompetent hale getirilmiş BL21 bakteri hücrelerine transformasyonu 
gerçekleştirilmiş ve ardından katı besiyerlerine ekimleri yapılarak gece boyunca 
büyümeye bırakılmıştır. Transformasyon işlemini kit kullanılarak gerçekleştirilen 
plazmid izolasyonu yöntemi takip etmiştir. Elde edilen plazmidlerin agaroz jel 
elektroforezi ile kontrolü yapıldıktan sonra Sanger DNA dizileme metoduyla 
mutasyonların eldesi doğrulanmıştır. 
Dört ayrı mutant protein oluşturmak ve saflaştırmak amacıyla, mutant cmFDH 
genleri aktarılmış BL21 hücrelerinin ampisilin içeren katı besiyerine ekimleri 
yapılmış ve gece boyunca büyümeye bırakılmıştır. Bir sonraki gün, yine ampisilinli 5 
ml besiyerinde gece boyunca büyümeye bırakılan hücreler, ertesi gün 100 ml 
hacmindeki sıvı besiyerine aktarılıp bir kez daha gece boyunca büyütüldükten sonra 
1 litrelik sıvı besiyerine transferi gerçekleştirilmiştir. Hücrelerin büyümeleri belli bir 
aşamaya geldikten sonra enzimlerin yüksek miktarda üretimi için hücre kültürüne 
IPTG eklenmiş ve böylece dört saatlik bir süreyle protein ekspresyonu indüklenmesi 
sağlanmıştır. Bu aşamadan sonra His-tag saflaştırma yöntemiyle rekombinant 
enzimler elde edilmiştir. Vektöre eklenmiş altı adet histidinle etiketlenmiş peptide, 
kullanılan nikelin bağlanmasıyla etiketlenmemiş proteinler kolona bağlanmadan 
geçmiş; etiketli proteinler ise saflaştırma tamponlarında bulunan imidazol molekülü 
sayesinde kolondan çıkarılarak elde edilmiştir. 
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Protein saflaştırma kontrolleri SDS-poliakrilamid jel elektroforezi (SDS-PAGE) 
yöntemiyle sağlanmıştır. Kullanılan belirteçlerle birlikte kıyaslama yapılarak tüm 
mutantlar için cmFDH enziminin büyüklüğüne denk gelecek şekilde 40 kDa 
seviyesinde tek bantlar gözlenmiştir. 
Son olarak yapılan kinetik çalışmalarla, enzimlerin kinetik özellikleri ve artan 
sıcaklıklarda katalitik aktiviteleri araştırılmıştır. cmFDH enziminin aktivitesi oda 
sıcaklığında; değişen format konsantrasyonlarına karşı NAD+ miktarının sabit 
tutulmasıyla birlikte; enzim, NAD+, format ve tampon çözeltiden oluşan reaksiyon 
karışım örneklerinin spektrofotometrede 340 nm dalga boyu altında verdiği 
absorbans değerlerindeki değişim şeklinde not edilmiştir. Değerlendirmeler her 
format konsantrasyonunda üçlü ölçümlerin aritmetik ortalaması üzerinden 
yapılmıştır. 
Mutant cmFDH enzimlerinin yüksek sıcaklıklara karşı gösterdiği tepkileri ölçmek 
için 25°C ve 65°C arasında; enzim, NAD+, format ve tampon çözelti 
konsantrasyonları sabit tutularak bu bileşenlerin oluşturduğu reaksiyon karışımlarının 
20 dakikalık bekleme süresinin ardından spektrofotometrede 340 nm dalga boyu 
altında verdiği absorbans değerlerindeki değişimler not edilmiştir. Değerlendirmeler 
bir kez daha üçlü ölçümlerin aritmetik ortalaması üzerinden yapılmıştır. 
Elde edilen sonuçlara göre dört mutant için ayrı ayrı termal denatürasyon profilleri 
çıkarılmıştır. Bu sonuçlara göre, M131A mutantının yüksek sıcaklıkta aktivitesinde 
düşüş görülmesine ve V139W mutantının yüksek sıcaklıkta aktivitesinde herhangi 
bir değişim göstermemesine karşın K301R ve V133I olmak üzere diğer iki mutantın 
termal stabilitelerinde kayda değer bir artış gözlenmiştir. Bunun yanında, enzimler 
üzerinde belirli bölgelerde yapılan değişikliklerin ardından, yalnız V139W 
mutantının katalitik aktivitesinde bir artış gözlemlenirken, elde edilen diğer üç 
mutant için katalitik aktivitelerin düştüğü gözlemlenmiştir. 
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1.  INTRODUCTION 
1.1 Enzymes 
Enzymes are biomolecules that act as biological catalysts for many specific 
biochemical reactions in living organisms. They have the potential of enhancing 
reaction rates up to 10
12
 folds with respect to uncatalyzed reaction, by lowering the 
activation energy level. They exhibit very high degree of specificity to their 
substrates. Only the structurally related components or sometimes only one type of a 
molecule can serve as a substrate for the enzyme, which is explained by “induced-
fit” hypothesis based on the perfect association of the enzyme-substrate complex via 
energy transfer between each other (Wilson & Walker, 2000). 
Table 1.1 : Six major groups of enzyme classification. 
 
 
Enzymes are classified into six main groups according to the reaction type they 
catalyze. The Enzyme Commission, which is established by the International Union 
of Biochemistry, developed a nomenclature to make the classification of the enzymes 
in 1964. According to this nomenclature, the reaction types and the enzyme families 
2 
catalyzing the reactions were divided into six groups, which were later divided in 
subgroups in series, such that a four-digit number representation with EC letters 
representing “Enzyme Commission” is available for the enzymes (Biochemistry, 
2002, section 8.1). The six major enzyme groups determined by the Enzyme 
Commission can be seen in Table 1.1. 
1.2 Formate Dehydrogenase (FDH) 
Formate is a molecule, which supports the growth of the several eukaryotic 
organism, eubacteria and archaebacteria. These organisms contain the enzyme 
formate dehydrogenase (FDH) to metabolize this compound. The FDH belongs to 
dehydrogenases group and catalyzes the reversible oxidation of formate to carbon 
dioxide (Ferry, 1990).  
1.2.1 Dehydrogenases 
All of the dehydrogenases belong to class of EC 1, which are oxidoreductases 
catalyzing oxidation and reduction reactions. Dehydrogenases require cofactors such 
as NAD
+
, NADP and FAD for the enzymatic activity and named according to 
differential requirement for these cofactors. 
1.2.2 General properties of FDH 
Formate dehydrogenases are the last enzymes used in metabolic pathway that 
catalyzes oxidation of formate molecule to carbon dioxide and water by reducing 
NAD
+
 to NADH. Three types of FDH are found in living organisms. They are 
NAD
+
-dependent formate dehydrogenases (EC 1.2.1.2), cytochrome-dependent 
formate dehydrogenases (EC 1.2.2.1) (Ferry, 1990) and NADP
+
-dependent formate 
dehydrogenases (Yamamoto, 1983). NAD
+
-dependent formate dehydrogenases have 
an important role in yeast and bacteria cells that use methane and methanol as carbon 
sources, since they are very effective in metabolism of C1 compounds. Cytochrome-
dependent formate dehydrogenases are responsible for anaerobic respiration in 
prokaryotic organisms (Popov & Lamzin, 1994). On the other hand, NADP
+
-
dependent formate dehydrogenases take part in methane metabolism. The reaction of 
FDH enzyme is shown in Figure 1.1. 
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Figure 1.1 : Reaction catalyzed by FDH. (Ordu & Karagüler, 2007) 
1.2.3 Structural features of NAD
+
-dependent FDH 
NAD
+ 
-dependent FDHs have molecular mass varying between 70 kDa and 100 kDa 
with consisting of two identical subunits, contains neither metal ions nor prosthetic 
groups and show high specificity to both formate and NAD
+
 (Schirwitz et al., 2007). 
According to the comparisons among FDHs from different organisms, strong 
similarities are revealed between primary structures of enzymes. FDH is found to be 
highly conserved enzyme due to identical 71 amino acid residues in 20% of all the 
sequence. Active site where catalytic activity is seen and the regions that are 
coenzyme bound are especially conserved in evolutionary period. Due to the fact 
that, all FDHs can be categorized in two groups: bacteria and plants, yeasts and 
fungi; 80-85% is the homology ratio between enzymes in the same group and 50-
55% is in different groups (Tishkov & Popov, 2004). 
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Figure 1.2 : Significant amino acid residues in FDH active site (Popov & Lamzin, 
1994). 
There are two deep channels in the active site of FDH. One of them is occupied by 
NAD
+
 coenzyme and the other one is occupied by the formate substrate. In Figure 
1.2, NAD
+
 is seen as the sphere in the medium, hydrophobic residues are seen in 
purple color, residues responsible for formate binding are seen in blue and 
responsible for carboxamide binding are seen in red colour (Popov & Lamzin, 1994). 
1.2.4 Catalytic properties of NAD
+
-dependent FDH 
NAD
+
-dependent FDH enzyme shows a Bi-Bi reaction in which NAD
+
 is used as the 
first substrate and is generally compatible with Michaelis-Menten kinetics by one 
active site functioning independently from another. Affinity for one substrate can be 
increased 3.5-fold by binding of other substrate. Catalytic properties of FDHs from 
different organism are shown in Table 1.2. 
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Table 1.2 : Catalytic properties of FDH from different organisms (Popov & Lamzin, 
1994). 
 
FDH functions optimum in pH 6.0-9.0 and shows ½ times lower performance in 
temperatures between 50
o
C and 60
o
C. FDH has the ability to function in wide range 
of pH values, whereas it is very sensitive to the high temperatures and tends to be 
inactive in such conditions. Most of NAD
+
-dependent formate dehydrogenases show 
high specificity to NAD
+ 
molecule and cannot use NADP
+
 as a coenzyme. On the 
contrary, Pseudomonas is an exception for this feature and has the potential to give 
reaction with both NAD
+
 and NADP
+
 by possessing two times more coenzyme 
specificity (Tishkov & Popov, 2004). 
1.2.5 Practical applications of FDH 
Presence of chirality in living world, optically active compounds are very important 
for the vital activity of cell. Chiral compounds, that contain an asymmetric, chiral, 
center, have two mirror-image forms which are called enantiomers. Moreover, 
optical purity refers to the difference between percentages of these enantiomers in a 
sample. Different optical isomers of the same compound may cause diseases since 
they have opposite physiological effects.  
According to prescriptions of Food and Drug Administration of USA, the optical 
purity of all chiral compounds used especially as drugs has to be no less than 99%. 
For that reason, number of studies on enzymes in pharmaceutical industry sharply 
increased in last decade. 
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Oxidoreductases, especially dehydrogenases can be used to produce optically active 
compounds from nonchiral ones since they are extremely stereospecific in transfer of 
hydride ion between substrate and coenzyme. Because of the high price of NADH 
and NADPH, regeneration of them would be economically favorable to decrease the 
cost of coenzymes to be used by dehydrogenases.  
 
Figure 1.3 : NAD(P)H regenaration system. 
Formate dehydrogenase has a high potential in the application of NAD(P)H 
regeneration process (See Figure 1.3). It has many advantages, to be applied on the 
cofactor regeneration reaction, which can be listed as follows: 
- Formate is a cheap substrate and the product of the reaction (CO2) can be 
easily removed since it forms in gas form.  
- FDH allows working in a wide range of pH with optimum catalytic activity. 
- The enzyme can be produced in methylotropic yeasts and bacteria reducing 
the production cost. 
- The reaction is irreversible and shifting the equilibrium of the main reaction 
by regeneration results in 99% yield. 
- FDHs from bacteria and yeast are able to be used in flow-through reactors for 
a while without being destabilized (Tishkov & Popov, 2006). 
1.3 Protein Engineering 
Protein engineering is the total process of improving desired features of proteins so 
that useful and functional novel proteins are constituted. There are three main 
approaches to manipulate the protein of interest (Leisola & Turunen, 2007). 
First approach is rational design in which detailed knowledge of structure and 
function of the protein has to be known. Site-directed mutagenesis is the prominent 
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technique for this strategy. The second approach is directed evolution in which 
random mutagenesis is used and gene libraries are constructed. Following screening 
methods help the scientists to make novel protein with desired features. The third 
protein engineering approach is semi-rational design that is the combination of these 
two strategies. Site-saturation mutagenesis is the key method used for that strategy. 
In brief; rational design proceeds from function to structure to sequence, whereas 
random approaches are with the aim of forming a sequence leads to a structure 
generating the desired function (See Figure 1.4). 
  
Figure 1.4.: Rational design (red arrow) and random approaches (Leisola & 
Turunen, 2007). 
1.3.1 Rational design 
1.3.1.1 Site – directed mutagenesis 
Rational design via site-directed mutagenesis is the most used protein engineering 
approach, that strongly needs detailed knowledge of structure and function 
associations of the enzyme. Site-directed mutagenesis technique aims to change an 
amino acid at a defined site with another desired amino acid based on conformational 
and structural knowledge about the protein. 
Development of the molecular model is the first step in rational design. It needs the 
usage of an appropriate algorithm. This is followed by experimental design and 
analysis of the characteristics of the desired protein. Advancement in many enzyme 
properties like changing coenzyme and substrate specifity, stability against oxidative 
stress, rational protein design has also been applied to improving the thermostability 
of several cases (Dalby, 2007).  
Changing of enzyme properties strongly requires manipulation of the primary 
structure of the protein. Only one single point mutation can lead to critical structural 
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and functional changes on the enzyme. By applying site-directed mutagenesis, 
protein properties may be changed by several ways, which may consist of 
optimization of electrostatic interactions, creating disulfide bridges, advanced core 
packing, condensing surface loops. In site-directed mutagenesis, the gene sequence is 
changed in computationally defined sites by performing polymerase chain reaction 
(PCR) with specific primers that carrying desired mutation (Rubingh, 1997). 
1.3.2 Directed evolution 
Directed evolution is the technique of protein variant preparation without any 
information about structural and functional relation of the protein. It depends on 
library creation of the enzymes which have been reached to the desired phenotype 
experimentally and requires application of effective selection and screening tools. 
Recently, directed evolution has been applied wide-range for both improving the 
enzymes and new metabolic pathways on desired activity. 
Directed evolution methods involve gene manipulation by DNA shuffling or in vitro 
recombination on purpose to acquire the desired phenotype with improve 
characteristics that does not exist naturally. DNA shuffling method depends on the 
homology of the proteins sequence and creation of hybrid sequences via reassembly 
of DNA fragment generated by whether restricted digestion or short PCR cycles. 
Thus, minimum 70% of homology between the genes is needed in order to 
recombine the sequences (Chen, 2001)..  
Random mutagenesis appears to be another significant approach in directed 
evolution. Error-prone PCR is a common application by using low fidelity DNA 
polymerases or decreasing the fidelity of the polymerase. Normally, the polymerases 
used in PCR create errors during the reaction. This feature is useful for random 
mutagenesis and can be increased by performing the reaction under non-optimal 
conditions such as increased polymerase concentration, extension time, concentration 
of Mg
2+
, addition of Mn
2+
 instead of Mg
2+
 and using unequal amounts of the four 
deoxyribonucleotides (Zhang and Ebright, 1989). 
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1.3.3 Semi – rational design 
1.3.3.1 Site – saturation mutagenesis 
Rational design allows manipulating the proteins from specific residues; on the other 
hand, directed evolution permits rapid engineering of proteins by mimicking the 
mechanism of natural selection and does not require any detailed structure of the 
protein. Both approaches appear to be powerful, however, both have limitations. 
Therefore, a “semi-rational” approach, saturation mutagenesis method, has been 
developed as a combination of both rational design and directed evolution. This 
method needs knowledge about the structure of the protein and is applied by 
mutagenesis around the site of interest as site-directed mutagenesis. The primers 
used in this technique are “degenerate” primers which vary for certain amino acids. 
Hence, a library containing multiple mutations of the site of interest are created as it 
is in directed evolution. 
1.4 Protein Engineering of Formate Dehydrogenase 
However, FDH enzyme is used in cofactor regeneration processes, native FDHs have 
some disadvantages for industrial applications such as: their operational stability is 
low, they do not use NADP
+
 as a cofactor, their production cost is high and they do 
not appear to be thermostable. Therefore, it is being engineered on purpose to desired 
feature improvements.  
Thermostability is one of the most important features of FDH to be engineered since 
it can be easily inactivated above a temperature 55-60°C (Popov et al., 1994). 
Increasing the thermostability of FDHs was studied by measurement of the enzyme’s 
residual activity upon incubation at a fixed temperature by introducing the Tm value 
(Tishkov et al., 2006). In the literature, various approaches have been applied to 
improve thermostability of FDH by either rational design or directed evolution.  
Researches on thermostable FDH ended up with varying results. Rojkova et al. 
(1999) reported that hydrophobization of α-helices within the protein results in 
higher thermostability with either single or different combinations of the mutations to 
the enzyme from Pseudomonas sp.101 which is known to be the most thermostable 
FDH. Slusarczyk et al. (2004) illustrated about 10-fold increase in thermal stability 
by directed evolution. According to the research, Glu151Asp and Arg178Ser results 
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in a distinguishable increase of thermostability. Moreover, Fedorchuck et al. (2002) 
authenticated the importance of interaction between the residues 43 and 61. They 
revealed that electrostatic repulsion between Asp43 and Glu61 gives the FDH from 
Mycobacterium vaccae by substitution of Glu61 with a non-negatively charged 
amino acid. 
1.5 Aim of the study 
The aim of the current study is to improve the thermostability of FDH from Candida 
metyhlica without hampering the enzyme activity. On this purpose, site-directed 
mutagenesis was applied on the target sites predicted by the computational design of 
flexible cavities (Yoo & Joo, 2009).  Such a rational and computational design 
strategy would reduce time and effort in engineering protein thermostability. Mutant 
design was performed by the combination of two structural features that are protein 
cavity and flexibility. In this strategy, number of  surface cavities were firstly 
identified on the enzyme according to the homology modelling studies, and the 
cavities with higher flexibility and that are considered to be thermo-labile were 
selected for the computational design. Also, the cavities with the potential of taking 
part in catalytic activity were excluded. Then, computational method was applied to 
the remaining appropriate residues and feasible mutations on these residues were 
suggested. In this study, some of those suggested mutants are selected and their 
effects on thermostability are investigated. 
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2.  MATERIALS & METHODS 
2.1 Materials 
2.1.1 Laboratory equipments and chemicals 
Laboratory equipments which are used during this study are given in Table 2.1. 
Table 2.1 :  Laboratory equipments. 
 
2.1.2 Chemicals, enzymes and kits 
The chemicals, enzymes and the kits that were used in this research study are given 
in Table 2.2. 
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Table 2.2 : Chemicals, enzymes and kits. 
 
2.1.3 Media for culture and transformation: Luria-Bertani (LB) and Optimal 
Broth with Catabolite repression (SOC) 
Luria Bertani (LB) agar medium together with the antibiotic, ampicillin, which was 
added just before the usage was used to grow the cell culture. Moreover, Super 
Optimal Broth with Catabolite repression (SOC) medium was used during the 
transformation and plating the cells to the plates containing LB agar medium. The 
contents of both media are available in Table 2.3. 
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Table 2.3 : Contents of LB agar and SOC media. 
 
2.1.4 Buffers and solutions 
2.1.4.1 TAE buffer (50X) 
50x TAE buffer was used in agarose gel electrophoresis to prepare the agarose gel 
that DNA was loaded on and as the tank buffer. 50x TAE buffer was used by diluting 
to 1x TAE buffer with dH2O. Preparation of 50x TAE is shown in Table 2.4. 
Table 2.4 : Preparation of 50X TAE buffer. 
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2.1.4.2 Protein prufication buffers 
Protein purification buffers were used for purifying proteins from bacterial pellet by 
6xHis-tagged purification method metal affinity chromatography and ion-exchange 
chromatography. Buffer types and their preparations are given below: 
Lysis buffer: 6.9 g NaH2PO4.2H2O (50mM), 17.54 g NaCl (300 mM) and 0.68 g 
imidazole (10 mM) were dissolved in 1 L dH2O and pH was adjusted to 8.0 using 
NaOH. 
Wash buffer: 6.9 g NaH2PO4.2H2O (50 mM), 17.54 g NaCl (300 mM) and 1.36 g 
imidazole (20 mM) were dissolved in 1 L dH2O and pH was adjusted to 8.0 using 
NaOH. 
Elution buffer: 6.9 g NaH2PO4.2H2O (50 mM), 17.54 mg NaCl (300 mM) and 17.0 
g imidazole (250 mM) were dissolved in 1 L: dH2O and pH was adjusted to 8.0 using 
NaOH. 
2.1.4.3 Buffers and solutions for SDS – PAGE analysis 
6x sample buffer  
6x sample buffer was used to denature protein samples which were loaded on SDS- 
polyacrylamide gel. Preparation of 6x sample buffer is shown in Table 2.5. 
Table 2.5 : Preparation of 6x sample buffer 
 
Tris – Tricine running buffer (10X) 
Tris-Tricine SDS Buffer (10x) is used as the electrophoresis running buffer during 
the stacking and resolve process of SDS-PAGE. Preparation of Tris-Tricine  buffer is 
shown Table 2.6.  
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It was only used one type of buffer instead of by using anode and cathode buffer 
which has different pH. Using one type of buffer gives good resolution and 
seperation to visualize small proteins. 
Table 2.6 : Preparation of Tris – Tricine buffer 
 
Coomassie Brilliant Blue (CBB) stain solution 
CBB stain solution was used to visualize separated protein bands on SDS 
polyacrylamide gel. Preparation of CBB stain solution is shown in Table 2.7. 
Table 2.7 : Preparation of CBB stain solution 
 
Destain solution 
Destain solution was used to visualize protein bands clearly by removing the 
background on SDS polyacrylamide gel. Preparations of CBB destain solution is 
shown in Table 2.8. 
Table 2.8 : Preparation of destain solution. 
 
2.1.5 pQE – 2 expression vector 
TAGZyme pQE-2 expression vector® which is produced by Qiagen was used for 
expression of mutant cmFDH. The vector is 4758 bp in length and contains 
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ampicillin resistance gene as the selective marker. It has also lac operator and lacIq 
repressor gene for gene expression regulation and uses T5 promoter. It also contains 
6xHis tag sequence to facilitate the protein purification. The wild-type FDH coding 
sequence was inserted to the multiple cloning site from SacI and PstI cleavage sites. 
2.1.6 BL – 21 cells 
Commercial BL-21(DE3) cells, which have been made artificially electrocompetent, 
were used for the transformation. It is widely used Eschericchia coli strain for 
protein expression. It contains λDE3 lysogen phage gene for the expression of T7 
polymerase providing high levels of protein expression. 
2.2 Methods 
2.2.1 Homology modelling and selection criteria for mutants 
The target sites to increase the thermostability of cmFDH were identified by 
homology modeling with Candida boidinii FDH and Pseudomonas sp. FDH. The 
structure of cmFDH was constructed by ExPASy portal with 2FSS (Candida boidiini 
FDH) and cofactor binding sites were predicted with 2NAD (Pseudomonas sp. 
FDH). Two structural features were shown to be important for the thermostability: 
protein cavity and flexibility. According to the result of the homology modeling, 6 
among the 14 cavities of FDH were found to be critical sites for thermostabilization 
without affecting the activity and cofactor binding.  Cavity 1, cavity 3, cavity 4, 
cavity 5, cavity 6, cavity 7 and cavity 14 were found to be the cavities with flexible 
region, that can be considered thermo-labile. However, cavity 7 was excluded due to 
the presence in the vicinity of the NAD
+
 binding site and intolerant to any mutation; 
therefore, the remaining 6 cavities were selected for mutation. Selected cavities are 
shown in Figure 2.1. 
In the consequence of computational analysis 14 residues were predicted to stabilize 
the flexible cavities which seem to stabilize the cavity-lining and neighboring 
residues. Among them Met131, Lys301, Val133 and Val139 are the residues found 
in the 1
st
, 6
th
 and 14
th
 cavities and selected for this study. The candidate residues and 
suggested mutants are seen in Table 2.9. Bold ones are the mutants selected for this 
study.  
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Figure 2.1 : Selected target cavities for the computational design (Yoo & Joo, 2009). 
Table 2.9 : The computational design of target cavities (Yoo & Joo, 2009). 
 
2.2.2 Site – directed mutagenesis 
Rational design via site-directed mutagenesis,is the most used protein engineering 
approach, that strongly needs detailed knowledge of structure and function 
associations of the enzyme. Site-directed mutagenesis technique aims to change 
amino acid at a defined site with another desired amino acid based on conformational 
and structural knowledge about the protein. Development of the molecular model is 
the first step in rational design. It needs the usage of an appropriate algorithm. This is 
followed by experimental design and analysis of the characteristics of the desired 
protein. Advancement in many enzyme properties like changing coenzyme and 
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substrate specifity, stability against oxidative stress, rational protein design has also 
been applied to improving the thermostability of several cases.  
Changing of enzyme properties strongly requires manipulation of the primary 
structure of the protein. Only one single point mutation can lead to critical structural 
and functional changes on the enzyme. By applying site-directed mutagenesis, 
protein properties may be changed by several ways which may consist of 
optimization of electrostatic interactions, creating disulfide bridges, advanced core 
packing, condensing surface loops. In site-directed mutagenesis, the gene sequence is 
changed in computationally defined sites by performing polymerase chain reaction 
(PCR) with specific primers that carrying desired mutation. 
In principle of site-directed mutagenesis, the gene sequence of interest is changed on 
computationally identified sites by performing PCR with specific primers. These 
primers should have desired mutations inside. In this study, primers were designed 
upon that procedure and are available in Figure 2.2, 2.3, 2.4, 2.5 below. 
 
Figure 2.2 : Mutagenesis PCR primers for M131A (F:forward, R:reverse). 
 
Figure 2.3 : Mutagenesis PCR primers for K301R (F:forward, R:reverse). 
 
Figure 2.4 : Mutagenesis PCR primers for V133I (F:forward, R:reverse). 
 
Figure 2.5 : Mutagenesis PCR primers for V139W (F:forward, R:reverse). 
The design of the primers was followed by mutagenesis PCR in order to amplify the 
new mutant DNA sequence. The components and conditions of the polymerase chain 
reaction are given in Table 2.10 and 2.11. 
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Table 2.10 :  Constituents and amounts of mutagenesis PCR. 
 
Table 2.11 : PCR conditions for amplification 
 
2.2.3 Control of PCR products 
The control of PCR products was performed by agarose gel electrophoresis. The 
plasmid with 5852 bp length (4758 bp pQE-2 vector + 1094 bp cmFDH sequence) 
was realized using 1% agarose gel. Firstly, 0.5 g agarose and 50 ml TAE buffer was 
mixed and heated until boiling with the help of a magnetic shaker. Then, the mixture 
was left to solidification via help of a rake to create the wells. Following the 
solidification the rake was removed and 3 μl of Lambda DNA/Eco RI+HindIII, 
Marker 3® by Fermantas was added into one of the wells. 5 μl of PCR products were 
mixed with 1 μl Ez-vision one DNA dye & buffer and added into the wells. Finally, 
the samples were run with 110 V for 20 minutes and the final gel was visualized 
under UV light. 
2.2.4 DpnI treatment 
The PCR products were treated by a restriction enzyme DpnI which recognizes the 
methylated Adenines and cleaves the methylated DNA. This methylation pattern is 
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seen in bacterial dam+ strains. Therefore, the vector carrying the original DNA 
sequence was eliminated from the product. The reaction was performed at 37°C with 
1 unit enzyme per 1 μg DNA for 4 hours. The product then was purified prior to the 
transformation. Restriction site of DpnI is given in Figure 2.6. 
 
Figure 2.6 : DpnI restriction site. 
2.2.5 PCR product purification 
Prior to the transformation the PCR products were purified following the DpnI 
treatment. The process was performed with PCR Product Purification Kit® by Intron 
Biotechnology. It started with addition of 500 μl binding buffer to the PCR product 
in 1.5 ml microcentrifuge tubes and incubation for 1 minute at room temperature. 
During the incubation, spin columns were placed in 2 ml collection tubes. Then, the 
sample was loaded to the spin column and centrifuged at 13000 rpm for 1 minute. 
The flow-through was discarded and 700 μl of washing buffer containing EtOH was 
added to the spin column and the assembly was centrifuged at 13000 rpm for 1 
minute. The tubes were recentrifuged with the same conditions after the removal of 
flow-through for drying the column and remove the residuals of the washing buffer. 
Finally, the spin columns were placed in new, sterile 2 ml tubes and 50 μl of elution 
buffer was added to the column. The tubes were incubated at room temperature for 1 
minute followed by centrifuge at 13000 rpm for 1 minute. The spin columns were 
then removed and transformation was performed with purified PCR products. 
2.2.6 Electrocompetent cell preparation 
Competent cells were prepared according to the following protocol: 
Cells are taken from a glycerol stock culture by scraping with a tip and it was 
directly put in a falcon containing 25 ml brock’s medium and incubated 3 days. 
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When optical density of culture is ~1.0 at 600 nm, the culture is cooled on ice at least 
15 min. Then, culture is spinned for 10 min at 3000 rpm and discarded supernant. 
Pellet is resuspended in 20 ml cold 20 mM 20% sucrose with pipette and centrifuged 
for 10 min. This step is repeated for 4 times by using 25, 10, 1 and 0.4 ml cold 
sucrose in resuspestion step. After final resuspesion step, cells were kept on ice and 
ready to electroporation process by the addition of proper amount of DNA. 
2.2.7 Transformation 
Transformation of PCR products to BL21 electrocompetent cells was performed via 
electroporator. On this purpose, firstly, 3 μl of PCR product was added to the 50 μl 
BL21 competent cells and mixed gently. Then, the solution was transferred to the 
electroporation cuvette and 1800 V electric voltage was applied. This process was 
immediately followed by addition of 250 μl of SOC medium to the cuvette at room 
temperature. The solution, then, was transferred to a new sterile tube and incubated 
for 1 hour at 37°C with 200 rpm.  
After the transformation, the cells carrying the mutant DNA were spread to the plates 
containing LB agar and 100 μg/ml ampicillin. The transfer of the cells was 
accompanied with SOC medium in two petri dishes in differing amounts of cells: 50 
μl of cell solution and 20 μl of cell solution plus 30 μl SOC medium. Finally, the 
plates were incubated overnight at 37°C.  
2.2.8 Plasmid isolation 
Colonies from the plate were taken and inoculated into the 5 ml LB liquid medium 
containing 100 μg/ml ampicillin. The cells, then, left for incubation at 37°C for 16 
hours. At the end of this period, 2 ml cells from each tube were transferred to the 2 
ml eppendorf tubes. The tubes were centrifuged at 13000 rpm for 3 minutes, the 
supernatant was discarded and plasmid isolation was performed from the cell pellet 
with High Pure Plasmid Isolation Kit® by Roche.  
First of all the binding buffer was placed on ice. Then, the pellet was resuspended 
with 250 μl RNase containing suspension buffer and mixed gently. 250 μl lysis 
buffer was added to the solution and mixed gently to homogenize. The mixture was 
incubated at room temperature for 5 minutes. Following the incubation, 350 μl of 
ice-cold binding buffer was added to the mixture and incubated on ice for 5 minutes 
22 
which was followed by centrifugation at 13000 rpm for 10 minutes. During this 
period High Pure Filter tubes were placed on the collection tubes. Then, the 
supernatant was transferred into the High Pure Filter tubes and centrifuged at 13000 
rpm for 1 minute. The liquid that passed through the collection tube was discarded 
and 500 μl of washing buffer I was added to the filter tubes followed by 
centrifugation at 13000 rpm for 1 minute. After the centrifugation, the liquid in the 
collection tube was removed and 700 μl of washing buffer II was added to the filter 
tube. The mixture was centrifuged again at 13000 rpm for 1 minute and the liquid in 
the collection tube was removed again. The tubes were recentrifuged at 13000 rpm 
for 1 minute in order to remove the residuals of the washing buffer. At the end of the 
centrifuge the collection tubes were removed and the filter tubes were placed on the 
microfuge tubes (1.5 ml). Finally, 100 μl of elution buffer was added to the filter tube 
and centrifuged for the last time at 13000 rpm for 1 minute. The filter tubes were 
removed; the tubes containing the plasmids were placed on +4°C before the control 
and concentration measurements. 
2.2.9 DNA sequencing 
After the insert checking on the agarose gel, sequencing of the isolated plasmids was 
performed by using dideoxynucleotides (ddNTPs). Each ddNTP is labeled with a 
fluorescent dye and they are used to arrest the nucleotide synthesis. Therefore, DNA 
fragments in different lengths will be formed with labeled terminal nucleotide. 
Separation of these fragments one by one via gel electrophoresis helps to find the 
order of the nucleotides. The alignment of sequences was performed by BLAST. 
2.2.10 Expression of cmFDH protein 
pQE-2 vector with cloned cmFDH gene was transformed into BL21 competent cells. 
They were spread on LB agar plate containing ampicillin and incubated overnight at 
37
o
C. The next day, selected colonies from plate were taken into 5 ml LB media 
(with ampicillin) in falcon tube and left for overnight growth at vigorous shaking at 
37
o
C. Then, 1 ml of overnight culture was diluted with LB media and placed into 100 
ml LB media. Culture was incubated with shaking at 37°C for overnight. Next day, 
the culture was transferred into 900 ml LB media (totally 1L) and after OD600 value 
of culture reaches 0.6, final concentration of 0.5 mM IPTG was added into culture 
with the incubation time of 4 hours to induce protein expression. 
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2.2.11 Ni – NTA purification of 6xHis tagged cmFDH protein 
After precipitation of cells containing mutant FDH proteins, purification protocol of 
proteins was applied as follows; precipitated cells treated with Lysis buffer  and 
disrupted by sonication process following lysosyme addition. 1.5 ml of 50% Ni-NTA 
agarose was added to lysates and the mixture was gently mixed for an hour in falcon 
tubes on ice at the room temperature. The resin was precipitated in that period and 
then was washed appropriate times with 1 ml of wash buffer. Finally, the protein was 
eluted appropriate times with 3ml elution buffer. 
2.2.12 SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) 
Tricine/polyacrylamide gel with 15% acrylamide concentration was prepared for 
expressed cmFDH which was expected to be around 32-45 kDa. Preparations of each 
part of gels are shown in Table 2.12 and 2.13. 
Table 2.12 : 15% separating gel solution (10ml) 
 
Table 2.13 : 5% stacking gel solution (4ml) 
 
The separating gel solution was applied into the gel cassette up to ± 6.5 cm, and, the 
last ± 2.5 cm of the cassette was filled with isopropanol, immediately. After the gel 
was polymerized for at least 3 min, the isopropanol was carefully removed by filter 
papers. The stacking gel solution was directly poured into the gel cassette, and the 
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gel comb was placed to form the slots. The stacking gel was polymerized for at least 
1 h.  
The samples, which were denaturated for 5 min at 95ºC, were loaded on the SDS 
PAGE gel. As molecular weight marker, Unstained Protein Molecular Weight 
Marker (Thermo Scientific), containing 7 unstained protein bands in the range of 
14.4-116 kDa, was loaded on the gel. 
Electrophoresis was carried out in anode and cathode buffers at constant 100 V.  
After electrophoresis, SDS-PAGE was stained in CBB stain solution. To reduce the 
time gel heated in a microwave oven for ~30 sec then placed on a shaker and then, it 
was destained in destain solution. 
2.2.13 cmFDH protein activity assay 
Activity of cmFDH protein was measured by using NAD(P)H and formate coupled 
assay. cmFDH activity was firstly determined at the room temperature with varying 
formate concentrations by the spectrophotometer under 340 nm wavelength. 
2.2.14 Thermal denaturation 
The mutant FDHs were aliquoted and incubated at at temperatures between 25°C to 
65°C for 20 min. in triplicate. Remaining activity measurements were performed at 
25°C in a reaction mixture containing 20 mM Tris Buffer at pH 8, 1 mM NAD+, 2 
mM formate and 0.4 μM enzyme. Each step included 3 measurements at a time of 1 
min. 
To calculate the concentration of cmFDH protein to be used in the reaction, the 
formula below was applied, where A represents for actual absorbance, ε for 
extinction coefficient of cmFDH, c for the concentration and ℓ for the pathlength 
which is taken 1 here. 
      
Since, the final absorbance value of 0.347 ng/μl (under 260 nm nanodrop 
measurement), and the extinction coefficient for the protein is 40344) the 
concentration of the M131A protein was estimated 6.76 μM from the formula given. 
For using final concentration of 0.4 μM of enzyme, the volume was determined by 
the formula given below. 
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    (1000 μl x 0.4 μM) / 6.76 μM = 59.17 μl 
The final absorbance values of K301R, V133I and V139W mutant proteins were 
2.537, 1.200 and 1.84 respectively. For using final concentration of 0.4 μM of 
enzyme, the volumes were determined with the same formula as 6.37 μl for K301R, 
13.33 μl for V133I and 8.77 μl for V139W. 
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3.  RESULTS AND DISCUSSIONS 
3.1 Mutagenesis PCR control 
After the PCR reactions for site directed mutagenesis to confirm amplified mutant 
FDH genes, agarose gel electrophoresis was applied. Then, monitoring under UV 
light revealed 5894 bp plasmid consisting of 4758 bp pQE-2 vector and 1094 bp 
FDH gene was observed. The image of the gel and the corresponding values of 
marker Lambda DNA/EcoRI+HindIII Marker 3 in the control are given in the Figure 
3.1. 
 
 
Figure 3.1 : Gel image comparison with marker. (a. Gel image of the plasmid with 
the marker in the first lane, M131A in the second lane, b. Lambda 
DNA/EcoRI+HindIII Marker 3). 
 
a b 
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3.2 Plasmid isolation 
Plasmid isolation from harvested cells was confirmed by another agarose gel 
electrophoresis. The gel image is shown in Figure 3.2. 
 
Figure 3.2 : Gel image of isolated plasmids. 
3.3 DNA sequencing and BLAST 
Plasmids were sequenced with 3 sequence primer (pQETypeIII, pQEPromoter and 
pQEReverse) of pQE-2 vector and performed Blast homology. These new mutant 
proteins were expected to contain alanine residue instead of methionine for M131A; 
arginine residue instead of lysine for K301R; isoleucine residue instead of valine for 
V133I; tryptophan residue instead of valine for V139W.  
The comparison of the wild-type and newly constructed mutant sequences is given in 
Figure 3.3 for M131A. The alignment of sequences was performed by BLAST. 
 
Figure 3.3 : The comparison of wild-type (WT) cmFDH and the mutant M131A. 
Figure 3.3 represents the comparison of native and mutant FDH sequences. Upper 
sequence is containing the GCC coding for the Alanine amino acid. The below 
represents the wild type sequence with ATG coding for Methionine amino acid in the 
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corresponding region to the GCC. The other nucleotides which are showed with dots 
stand for the unchanged, non-mutant nucleotides.  
The comparison of the wild-type and newly constructed mutant sequences is given in 
Figure 3.4 for K301R. The alignment of sequences was performed by BLAST. 
 
Figure 3.4 : The comparison of wild-type (WT) cmFDH and the mutant K301R. 
The upper row of the Figure 3.4 represents the mutant sequence containing the CGT 
sequence coding for the Arginine amino acid. Figure 3.4 represents the wild-type 
sequence with AAA coding for Lysine amino acid in the corresponding region to the 
CGT. The other nucleotides which are showed with dots stand for the unchanged, 
non-mutant nucleotides.  
The comparison of the wild-type and newly constructed mutant sequences is given in 
Figure 3.5 for V133I. 
 
Figure 3.5 : The comparison of wild-type (WT) cmFDH and the mutant V133I. 
The upper row of the Figure 3.5 represents the mutant sequence containing the ATT 
sequence coding for the Isoleucine amino acid. The below, represents the wild-type 
sequence with GTC coding for Valine amino acid in the corresponding region to the 
ATT. The other nucleotides which are showed with dots stand for the unchanged, 
non-mutant nucleotides.  
The comparison of the wild-type and newly constructed mutant sequences is given in 
Figure 3.6 for V139W. 
29 
 
Figure 3.6 : The comparison of wild-type (WT) cmFDH and the mutant V139W. 
The upper row of the Figure 3.6 represents the mutant sequence containing the TGG 
sequence coding for the Tryptophane amino acid. Figure 3.6 represents the wild-type 
sequence with GTT coding for Valine amino acid in the corresponding region to the 
TGG. The other nucleotides which are shown with dots stand for the unchanged, 
non-mutant nucleotides. 
3.4 Protein purification control (SDS – PAGE) 
pQE-2 expession vector containing mutant cmFDH genes was overexpressed 
expression strain of E.coli BL21. To determine the purification of cmFDH with IPTG 
induction, total protein samples were analyzed by SDS-PAGE method. The results 
showed that IPTG induction gives a proper band around 40kDa seen in Figure 3.7 for 
M131A, Figure 3.8 for K301R, Figure 3.9 for V133I AND Figure 3.10 for E272W. 
 
Figure 3.7 : SDS – PAGE analysis of total protein sample for M131A expression. 
40 kDa 
Marker 
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Figure 3.8 : SDS – PAGE analysis of total protein sample for K301R expression. 
(M: Marker; W1-W5: Wash 1-Wash 5; E1-E5: Elution 1-Elution 5) 
 
Figure 3.9 : SDS – PAGE analysis of total protein sample for V133I expression.  
(M: Marker; W1-W4: Wash 1-Wash 4; E1-E5: Elution 1-Elution 5) 
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Figure 3.10 : SDS – PAGE analysis of total protein sample for V139W expression. 
(M: Marker; W1-W4: Wash 1-Wash 4; E1-E5: Elution 1-Elution 5) 
3.5 Steady State Kinetics 
Kinetic measurements of mutant enzymes were carried out at 25°C in a reaction 
mixture containing 20 mM Tris Buffer at pH 8, 1 mM NAD
+
, 0–40 mM formate and 
0.4 μM enzyme (Mr 40344). All kinetic parameters presented in this study are the 
mean values derived from triplicate measurements. Data were analysed using Grafit5 
Kinetics Software. The activity results after spectrophotometric measurements for 
M131A mutant enzyme are given in Figure 3.11. As a result, Km value of M131A 
mutant was determined 4.1339 and Vmax was found 0.1350. kcat value was calculated 
as 0.90 for M131A. 
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Figure 3.11 : Kinetics data of M131A. 
The activity results after spectrophotometric measurements for K301R mutant 
enzyme are given in Figure 3.12. As a result, Km value of K301R mutant was 
determined 12,8218 and Vmax was found 0.1484. kcat value was calculated as 1.00 for 
K301R. 
 
Figure 3.12 : Kinetics data of K301R. 
The activity results after spectrophotometric measurements for V133I mutant 
enzyme are given in Figure 3.13 and results for V139W are given in Figure 3.14. As 
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a result, Km value of V133I mutant was determined 5.5265 and Vmax was found 
0.0248. kcat value was calculated as 0.17 for V133I. Additionally, Km value of 
V139W mutant was determined 3.5777; Vmax was determined as 0.1375. kcat value 
was calculated as 0.92 for V139W. 
 
Figure 3.13 : Kinetics data of V133I. 
 
Figure 3.14 : Kinetics data of V139W. 
According to the results, kinetic characteristics of the new mutants were compared to 
wild type FDH. All data can be seen in Table 3.1. 
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Table 3.1 : Comparison of kinetic results with native FDH. 
 
3.6 Thermal Denaturation 
One of the approaches in the literature to characterize enzyme thermostability is to 
measure the residual enzyme activity upon incubation at a fixed temperature for a 
fixed time (Thiskov and Popov, 2006). In this study, enzyme was aliquoted and 
incubated at a series of temperatures for a period of 20 minutes and the residual 
activity was recorded by using UV spectrophotometer. Figures 3.15 to 3.18 
demonstrate the thermal inactivation profile of mutants M131A, K301R, V133I, 
V139W respectively. 
 
Figure 3.15 : Remaining activities of M131A against increasing temperatures. 
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Figure 3.16 : Remaining activities of K301R against increasing temperatures. 
 
Figure 3.17 : Remaining activities of V133I against increasing temperatures. 
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Figure 3.18 : Remaining activities of V139W against increasing temperatures. 
The temperature that 50% of the enzyme becomes denaturation was determined as 
56.1ºC for M131A as shown in Figure 3.15. T0.5 values for the other mutants are seen 
as 57.4; 57.5 and 56.7 for K301R, V133I, V139W respectively. Thermal 
denaturation profiles of the four mutants compared to wild type FDH are 
summarized in Table 3.2. 
Table 3.2 : The denaturation profiles of wild type and mutants 
 
When the kinetic activity results of the new mutant enzymes are compared, it can be 
concluded from kcat / Km values that catalytic efficiencies of the new mutant enzymes 
were apparently changed with respect to native FDH. It can clearly be seen that 
K301R has the less affinity for formate molecule as its substrate since the mutant has 
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higher Km value that others. Besides that, V133I was observed with the lowest 
turnover number of 0,17 when compared to other mutants. With the Km value of 
3.5777 and kcat value of 0.92, V139W can be considered as the mutant with the most 
catalytic activity remaining. This mutant was also the only one with improved 
catalytic efficiency since the kcat / Km value of the mutant increased from 0.24 to 
0.26. 
According to the thermal denaturation profiles of enzymes resulted after incubation 
at a series of temperatures for a period of 20 minutes, it can be concluded that the 
mutant gained the most thermostability became V133I. The temperature shift of T0,5 
point for it was 0.8 in a positive manner. Also the change in the thermostability of 
K301R mutant was considerably positive and very close to V133I. M131A has lost 
some of its thermostability with the T0,5 value of 56.1 since the native T0,5 of FDH is 
accepted 56.7ºC. Interestingly, no considerable change was seen in the stability of 
V139W mutant since it has the same T0,5 value of 56.7ºC with native cmFDH. V133I 
and V139W have the mutant residues in the same cavity but their different T0.5 
values after mutations may be explained by the introduction of a bulky hydrophobic 
residue which is tryptophane in V139W and possible hydrophobic interactions with 
the neighboring residues. Such interactions and a possible steric hindrance could 
prevent the enzyme gaining more stable structure at increasing temperatures. As a 
result, no considerable change was seen in the thermal denaturation profile of 
V139W. 
As an alternative strategy to the single mutations, the combination of double, triple 
and even quadruple mutants in the surface cavities with the suggested mutants may 
be of interest for future studies to improve the thermostability of cmFDH. 
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4.  CONCLUSION 
Protein engineering studies are based on modifying the sequence and the structure of 
a protein with the aim of creating enzymes with improved functional properties. In 
this project, it is shown that gaining enzymes with improved thermostability is 
possible. Site-directed mutagenesis of particular residues in thermostability; M131, 
K301, V133 and V139 from cmFDH coupled with kinetic activity assays has resulted 
in promising mutants with consisting stability in higher temperatures. 4 candidate 
mutants have been observed with increased thermal denaturation points. These 
results reveal that, the selected residues are important in controlling thermostability 
of formate dehydrogenases and may be used in initial steps of further studies to 
develop cmFDH enzymes with more stability in high temperatures. In these studies; 
combination of double, triple and quadruple mutants in suggested residues will most 
likely have the potential of gaining much increased thermostability. 
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